Abstract
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV2), though primarily a respiratory pathogen, also involves the gastrointestinal tract. Similar to the respiratory mucosa, angiotensin converting enzyme-2 (ACE-2) receptor and transmembrane serine protease 2 (TMPRSS2) co-express in the gastrointestinal tract, which facilitates viral entry into the tissue. Less than 10% of children with infection develop diarrhea and vomiting. Prolonged RT PCR positivity in the stool has raised the possibility of feco-oral transmission. Elevated transaminases are common, especially in those with severe coronavirus disease (COVID-19). Children with inflammatory bowel disease and post liver transplant patients do not have an increased risk of disease, and should remain on medications they are already on. Children with chronic liver disease should continue their medications as usual. All elective procedures like endoscopy should be postponed.
Article PDF
Similar content being viewed by others
References
Hindson J. COVID-19: Faecal-oral transmission? Nature Rev Gastroenterol Hepatol. 2020. Available from https://www.nature.com/nrgastro/s41575-020-0295-7. Accessed March 30, 2020.
Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y,et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nature Med.2020. Available from: https://www.nature.com/naturemedicine/s41591-020-08174. Accessed March 15,2020.
Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 infection in children. New England J Med. 2020. Available from: https://www.nejm.org/NEJMc2005073. Accessed March 29, 2020.
Jin X, Lian J-S, Hu JH, Gao J, Zheng L, Zhang YM, et al. Epidemiological, clinical and virological characteristics of 74 cases of corona virus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut.2020. Available from: https://gut.bmj.com/gutjnl-2020-320926. Accessed March 20, 2020.
Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H.Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020. Available from: https://www.gastrojournal.org/j.gastro.2020.02.05. Accessed March 27, 2020.
Pan L, Mu M, Ren HG, Yang P, Sun Y, Wang R,et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020. Available from: https://journals.lww.com/ajg/ajg.0000000000000620. Accessed March 31, 2020.
Danese S, Cecconi M, Spinelli A. Management of IBD during the COVID-19 outbreak: Resetting clinical priorities. Nature Rev Gastroenterol Hepatol.2020. Available from: https://www.nature.com/nrgastro/s41575-020-0294-8. Accessed March 30, 2020.
Mao R, Liang J, Shen J, Ghosh S, Zhu LR,Yang H, et al on behalf of the Chinese Society of IBD, Chinese Elite IBD Union, and Chinese IBD Quality Care Evaluation Center Committee. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020. Available from: https://www.thelancet.com/langas/S2468-1253(20)30076-5. Accessed March 30, 2020.
Zhang c, Shi 1, Wang F-S. Liver injury in COVID-19: Management and challenges. Lancet Gastroenterol Hepatol. 2020. Available from: https://www.thelancet.com/gastrohep>S246812532030057-1. Accessed April 06, 2020.
Bangash MN, Patel J, Patrekh D. COVID-19 and the liver: Little cause for concern. Lancet GastroenterolHepatol. 2020. https://www.thelancet.com/gastrohepS2468-1253(20)30084-4. Accessed April 06, 2020.
Author information
Authors and Affiliations
Consortia
Contributions
JM: as chairman coordinated and edited the paper; NS authored the segment on Liver; PS the segment on intestine. All authors participated in finalizing the paper.
Corresponding author
Rights and permissions
About this article
Cite this article
Matthai, J., Shanmugam, N., Sobhan, P. et al. Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children. Indian Pediatr 57, 533–535 (2020). https://doi.org/10.1007/s13312-020-1851-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-020-1851-5